Atossa Therapeutics
ATOS
#9384
Rank
โ‚ฌ74.89 M
Marketcap
0,58ย โ‚ฌ
Share price
-4.62%
Change (1 day)
-39.67%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚ฌ26.87 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.62 Million, an increase over its 2023 earnings that were of -โ‚ฌ25.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ26.87 Million24.27%
2024 -โ‚ฌ21.62 Million-15.25%
2023 -โ‚ฌ25.51 Million11.62%
2022 -โ‚ฌ22.85 Million30.84%
2021 -โ‚ฌ17.47 Million15.58%
2020 -โ‚ฌ15.11 Million3.41%
2019 -โ‚ฌ14.62 Million51.16%
2018 -โ‚ฌ9.67 Million40.41%
2017 -โ‚ฌ6.89 Million27.54%
2016 -โ‚ฌ5.4 Million-47.49%
2015 -โ‚ฌ10.28 Million-17.25%
2014 -โ‚ฌ12.43 Million35.91%
2013 -โ‚ฌ9.15 Million112.3%
2012 -โ‚ฌ4.31 Million46.53%
2011 -โ‚ฌ2.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.45 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.12 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.09 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.65 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ35.32 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ92.56 Million 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA